Skip to main content

ICPE 2022 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Anouk Deruaz-Luyet

Boehringer Ingelheim International GmbH, Germany

Boehringer Ingelheim International GmbH (Employment)IQVIA AG (Employment)

Presentation(s):

Effectiveness and Safety of Empagliflozin in Routine Care: Results from the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) Study
Friday, August 26, 2022
6:15 PM – 6:20 PM CEST
Cardiovascular Effectiveness of Empagliflozin vs. Glucagon-like peptide-1 Receptor Agonists or Liraglutide in the EMPRISE Study
Sunday, August 28, 2022
9:30 AM – 9:45 AM CEST